231
Views
24
CrossRef citations to date
0
Altmetric
Review

Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives

&
Pages 159-169 | Published online: 08 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pustika A. Wahidiyat, Teny T. Sari, Ludi D. Rahmartani, Stephen D. Iskandar, Anastasia M. Pratanata, Ivana Yapiy, Iswari Setianingsih, Tubagus D. Atmakusuma & Anna M. Lubis. (2022) Thalassemia in Indonesia. Hemoglobin 46:1, pages 39-44.
Read now

Articles from other publishers (22)

Wenyan Yu, Bingbing Liu, Lei Zhou, Enpeng Gong, Chengyuan Che, Jianchao Zhou, Zhenzhong Zhang, Junjie Liu & Jinjin Shi. (2023) The Development of Drug Delivery Systems for Efficient Intracranial Hemorrhage Therapy. Advanced Healthcare Materials 12:12.
Crossref
Giovanni Caocci, Olga Mulas, Susanna Barella, Valeria Orecchia, Brunella Mola, Alessandro Costa, Fabio Efficace & Giorgio La Nasa. (2023) Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy. Journal of Clinical Medicine 12:7, pages 2547.
Crossref
Ashley E Sam, Zachary Weber, Alejandra Peña, Cody Henderson, Jonathan M King & Nicholas R Carr. (2023) A pilot study to evaluate clinical factors associated with iron and ferritin elevations during pediatric extracorporeal membrane oxygenation. Perfusion, pages 026765912311547.
Crossref
Yuwei Zeng, Chuang Huang, Dongming Duan, Aiju Lou, Yuan Guo, Tianhua Xiao, Jianguo Wei, Song Liu, Zhao Wang, Qihao Yang, Lei Zhou, Zenghui Wu & Le Wang. (2022) Injectable temperature-sensitive hydrogel system incorporating deferoxamine-loaded microspheres promotes H-type blood vessel-related bone repair of a critical size femoral defect. Acta Biomaterialia 153, pages 108-123.
Crossref
Sashoy Patterson, Ashley Singleton, Jane Branscomb, Vivien Nsonwu & Regena Spratling. (2022) Transfusion Complications in Thalassemia: Patient Knowledge and Perspectives. Frontiers in Medicine 9.
Crossref
Victoria Wolf, Yasir Abdul & Adviye Ergul. (2022) Novel Targets and Interventions for Cognitive Complications of Diabetes. Frontiers in Physiology 12.
Crossref
Akram Bardestani, Shiva Ebrahimpour, Ali Esmaeili & Abolghasem Esmaeili. (2021) Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles. Journal of Nanobiotechnology 19:1.
Crossref
Erika Fayina Marie. (2021) Moxibustion with deferasirox results in safe, accelerated, and sustained cardiac iron chelation for a young Diamond Blackfan Anemia patient: An integrative case report. EXPLORE 17:3, pages 239-246.
Crossref
Guimei Zhang, Yaru Zhang, Yanxin Shen, Yongchun Wang, Meng Zhao & Li Sun. (2021) The Potential Role of Ferroptosis in Alzheimer’s Disease. Journal of Alzheimer's Disease 80:3, pages 907-925.
Crossref
Amy Corbin Farr & May P. Xiong. (2020) Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage. Molecular Pharmaceutics 18:2, pages 593-609.
Crossref
Carlos Ros, Jan Bieri & Remo Leisi. (2020) The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with Biotechnological Applications. Viruses 12:12, pages 1463.
Crossref
Pustika Amalia Wahidiyat, Teny Tjitra Sari, Ludi Dhyani Rahmartani, Iswari Setianingsih, Stephen Diah Iskandar, Anastasia Michelle Pratanata, Ivana Yapiy, Mikhael Yosia & Fernando Tricta. (2020) An insight into Indonesian current thalassaemia care and challenges. ISBT Science Series 15:3, pages 334-341.
Crossref
Paolo Ricchi, Antonella Meloni, Silvia Costantini, Anna Spasiano, Patrizia Cinque, Biagio Gargiulo, Alessia Pepe & Aldo Filosa. (2020) Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors. Annals of Hematology 99:6, pages 1209-1215.
Crossref
Sarah Allegra, Jessica Cusato, Silvia De Francia, Filomena Longo, Elisa Pirro, Davide Massano, Valeria Avataneo, Amedeo De Nicolò, Antonio Piga & Antonio D’Avolio. (2019) The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. The Pharmacogenomics Journal 19:5, pages 417-427.
Crossref
Ilias Georgalas, Georgios Makris, Dimitrios Papaconstantinou, Petros Petrou, Evangelia Chalkiadaki, Konstantinos Droutsas, Konstantinos Andreanos & Menelaos Kanakis. (2019) A Pilot Optical Coherence Tomography Angiography Study on Superficial and Deep Capillary Plexus Foveal Avascular Zone in Patients With Beta-Thalassemia Major. Investigative Opthalmology & Visual Science 60:12, pages 3887.
Crossref
Enikő Balogh, György Paragh & Viktória Jeney. (2018) Influence of Iron on Bone Homeostasis. Pharmaceuticals 11:4, pages 107.
Crossref
Nour M. Moukalled, Fuad A. El Rassi, Sally N. Temraz & Ali T. Taher. (2018) Iron overload in patients with myelodysplastic syndromes: An updated overview. Cancer 124:20, pages 3979-3989.
Crossref
Ruben Jauregui, Karen Sophia Park, Alexander G. Bassuk, Vinit B. Mahajan & Stephen H. Tsang. (2018) Deferoxamine-induced electronegative ERG responses. Documenta Ophthalmologica 137:1, pages 15-23.
Crossref
Maria Domenica Cappellini, John B. Porter, Vip Viprakasit & Ali T. Taher. (2018) A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?. Blood Reviews 32:4, pages 300-311.
Crossref
Linhao You, Jing Wang, Tianqing Liu, Yinlong Zhang, Xuexiang Han, Ting Wang, Shanshan Guo, Tianyu Dong, Junchao Xu, Gregory J. Anderson, Qiang Liu, Yan-Zhong Chang, Xin Lou & Guangjun Nie. (2018) Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice. ACS Nano 12:5, pages 4123-4139.
Crossref
D. Maira, E. Cassinerio, A. Marcon, M. Mancarella, M. Fraquelli, P. Pedrotti & M. D. Cappellini. (2017) Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT). Annals of Hematology 96:11, pages 1931-1936.
Crossref
Viktória Jeney. (2017) Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss. Frontiers in Pharmacology 8.
Crossref